Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Zimmer Biomet Holdings Inc    ZBH

Delayed Quote. Delayed  - 10/27 10:02:01 pm
120.99 USD   -0.07%
09:01p ZIMMER BIOMET : Oct 27, 2016 Zimmer Biomet Acquires RespondWell® Tel..
10/26 ZIMMER BIOMET : Oct 26, 2016 Zimmer Biomet Announces Positive Compar..
10/26ZIMMER BIOMET H : quaterly earnings release
News SummaryMost relevantAll newsSector news 

Biomet 3Q Loss Widens On Charges; Sales Grow 5%

share with twitter share with LinkedIn share with facebook
share via e-mail
04/11/2012 | 04:51pm CEST

("Biomet 3Q Loss Widens On Charges; Sales Grow 5%," at 7:03 a.m. EDT, misstated the hip sales increase in the sixth paragraph. The correct version follows:)

Biomet Inc.'s fiscal third-quarter loss widened on merger-related costs as strong sales for sports medicine, extremities and trauma helped drive the orthopedic medical-device maker's top-line growth.

Though privately held, Biomet's results are closely watched because the company reports earlier than larger competitors--such as Zimmer Holdings Inc. (>> Zimmer Holdings, Inc.), Stryker Corp. (SYK) and Johnson & Johnson (>> Johnson & Johnson)--and could foreshadow industry trends.

Biomet has seen its losses widen in recent quarters, weighed down by charges related to its $11.4 billion buyout in 2007 by a private-equity consortium including affiliates from The Blackstone Group, Goldman Sachs Capital Partners, Kohlberg Kravis Roberts & Co. and TPG. Sales have also been weak as patients, worried about out-of-pocket costs or long absences from work to recover, opt to defer hip and knee-replacement procedures. Biomet has said it is unclear when demand will come back.

For the quarter ended Feb. 29, Biomet reported a loss of $16.5 million, compared with a loss of $11.6 million a year earlier. Excluding merger and other special items, adjusted earnings fell to $55.1 million from $63.8 million. Sales jumped 4.5% to $708.9 million.

Gross margin slipped to 69% from 69.3%.

The company, which distributes products in about 90 countries, said worldwide hip sales increased 6%, while worldwide knee sales grew 4%. Sales for sports medicine, extremities and trauma were up 16%, while the spine and bone healing segment saw a 5% drop.

U.S. sales grew 5% while Europe sales rose 2.1%. International sales, which include Canada, South America, Mexico and the Asia-Pacific region, jumped 7.2%.

Last week, Biomet made a binding offer to acquire the global trauma business of Johnson & Johnson's DePuy Orthopaedics Inc. for about $280 million in cash, a deal the company said would greatly expand its sports, extremities and trauma business. Biomet also recently agreed to pay $23 million in penalties to settle U.S. allegations that it bribed doctors in Brazil, China and other countries over a period of years.

--By Anne Pallivathuckal and Melodie Warner, Dow Jones Newswires; 212-416-2283; melodie.warner@dowjones.com

Stocks mentioned in the article : Zimmer Holdings, Inc., Johnson & Johnson
share with twitter share with LinkedIn share with facebook
share via e-mail
09:01p ZIMMER BIOMET : Oct 27, 2016 Zimmer Biomet Acquires RespondWell® Telerehabilitat..
10/26 ZIMMER BIOMET : Oct 26, 2016 Zimmer Biomet Announces Positive Comparative Data f..
10/26ZIMMER BIOMET HOLDINGS INC : quaterly earnings release
10/25 ZIMMER BIOMET : Oct 25, 2016 Zimmer Biomet's Mobi-C® Cervical Disc Becomes Most ..
10/19 ZIMMER BIOMET : The Orthopaedic Research and Education Foundation and Orthopaedi..
10/06 ZIMMER BIOMET : Oct 6, 2016 Zimmer Biomet Announces Live Audio Webcast and Confe..
10/05 ZIMMER BIOMET HOLDINGS, INC. : Entry into a Material Definitive Agreement, Creat..
09/29 ZIMMER BIOMET : Launches VANGUARD® Individualized Design Knee Replacement
09/28 ZIMMER BIOMET : Contributes Additional $100,000 in Funding to the Orthopaedic Re..
09/22 ZIMMER BIOMET : Sep 22, 2016 Zimmer Biomet Contributes Additional $100,000 in Fu..
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
10/19DJST JUDE MEDICAL : Sales Rise 12% -- Update
10/19DJAbbott Labs Swings to Loss After Booking Charge on Mylan Stake
10/18DJST JUDE MEDICAL : Forms Cybersecurity Advisory Group
10/14 Private equity firms line up bids for BSN Medical - sources
10/11DJST JUDE MEDICAL : Warns of Battery Problems With Heart Products -- 3rd Update
More sector news : Medical Equipment, Supplies & Distribution - NEC
News from SeekingAlpha
10/18 Medtech To Hit $530bn In 2022, Fueled By Diagnostics And Neurology
10/17 Game Plan For The Week - Cramer's Mad Money (10/14/16)
10/10 Consistent Excellence Continues To Drive Stryker Higher
09/20 Zimmer Biomet launches VANGUARD Individualized Design Knee Replacement
09/15 Zimmer Biomet acquires Dutch firm Clinical Graphics
Financials ($)
Sales 2016 7 703 M
EBIT 2016 2 472 M
Net income 2016 547 M
Debt 2016 10 046 M
Yield 2016 0,76%
P/E ratio 2016 48,14
P/E ratio 2017 18,30
EV / Sales 2016 4,45x
EV / Sales 2017 4,09x
Capitalization 24 218 M
More Financials
Duration : Period :
Zimmer Biomet Holdings Inc Technical Analysis Chart | ZBH | US98956P1021 | 4-Traders
Full-screen chart
Technical analysis trends ZIMMER BIOMET HOL...
Short TermMid-TermLong Term
Technical analysis
Income Statement Evolution
More Financials
Mean consensus OUTPERFORM
Number of Analysts 27
Average target price 141 $
Spread / Average Target 16%
Consensus details
EPS Revisions
More Estimates Revisions
David C. Dvorak President, Chief Executive Officer & Director
Larry C. Glasscock Non-Executive Chairman
Robin T. Barney Senior VP-Global Operations & Logistics
Daniel P. Florin Chief Financial Officer & Senior Vice President
David J. Kunz VP-Global Quality, Clinical & Regulatory Affairs
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
MEDTRONIC PLC5.46%112 103
C R BARD INC13.47%15 789
TERUMO CORP9.70%14 797
More Results